APOLLO ENDOSURGERY INC (APEN) Fundamental Analysis & Valuation

NASDAQ:APEN • US03767D1081

10 USD
+0.08 (+0.81%)
At close: Apr 3, 2023
9.99 USD
-0.01 (-0.1%)
After Hours: 4/3/2023, 8:15:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This APEN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

Taking everything into account, APEN scores 1 out of 10 in our fundamental rating. APEN was compared to 184 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of APEN have multiple concerns. APEN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. APEN Profitability Analysis

1.1 Basic Checks

  • In the past year APEN has reported negative net income.
  • APEN had a negative operating cash flow in the past year.
APEN Yearly Net Income VS EBIT VS OCF VS FCFAPEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -10M -20M -30M -40M

1.2 Ratios

  • APEN has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
APEN Yearly ROA, ROE, ROICAPEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 -200 -400 -600 -800 -1K

1.3 Margins

  • APEN has a Gross Margin of 55.20%. This is comparable to the rest of the industry: APEN outperforms 52.58% of its industry peers.
  • APEN's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for APEN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.92%
GM growth 5Y-2.23%
APEN Yearly Profit, Operating, Gross MarginsAPEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 20 -20 40 -40 60 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. APEN Health Analysis

2.1 Basic Checks

  • APEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • APEN has more shares outstanding than it did 1 year ago.
  • The debt/assets ratio for APEN is higher compared to a year ago.
APEN Yearly Shares OutstandingAPEN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M
APEN Yearly Total Debt VS Total AssetsAPEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

2.2 Solvency

  • APEN has an Altman-Z score of -0.16. This is a bad value and indicates that APEN is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -0.16, APEN is doing worse than 60.56% of the companies in the same industry.
  • APEN has a Debt/Equity ratio of 1.04. This is a high value indicating a heavy dependency on external financing.
  • Looking at the Debt to Equity ratio, with a value of 1.04, APEN is doing worse than 79.34% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.04
Debt/FCF N/A
Altman-Z -0.16
ROIC/WACCN/A
WACC10.2%
APEN Yearly LT Debt VS Equity VS FCFAPEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 20M -20M 40M 60M

2.3 Liquidity

  • A Current Ratio of 2.35 indicates that APEN has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.35, APEN is doing worse than 66.20% of the companies in the same industry.
  • APEN has a Quick Ratio of 1.89. This is a normal value and indicates that APEN is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.89, APEN is not doing good in the industry: 60.56% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.35
Quick Ratio 1.89
APEN Yearly Current Assets VS Current LiabilitesAPEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. APEN Growth Analysis

3.1 Past

  • The earnings per share for APEN have decreased by -9.99% in the last year.
  • APEN shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.01%.
  • APEN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.63% yearly.
EPS 1Y (TTM)-9.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.21%
Revenue 1Y (TTM)22.01%
Revenue growth 3Y14.87%
Revenue growth 5Y3.63%
Sales Q2Q%31.8%

3.2 Future

  • APEN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.79% yearly.
  • APEN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 33.84% yearly.
EPS Next Y13.1%
EPS Next 2Y11.79%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year18.29%
Revenue Next 2Y20.22%
Revenue Next 3Y33.84%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
APEN Yearly Revenue VS EstimatesAPEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
APEN Yearly EPS VS EstimatesAPEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. APEN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for APEN. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for APEN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
APEN Price Earnings VS Forward Price EarningsAPEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
APEN Per share dataAPEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.79%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. APEN Dividend Analysis

5.1 Amount

  • No dividends for APEN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

APEN Fundamentals: All Metrics, Ratios and Statistics

APOLLO ENDOSURGERY INC

NASDAQ:APEN (4/3/2023, 8:15:00 PM)

After market: 9.99 -0.01 (-0.1%)

10

+0.08 (+0.81%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-30
Earnings (Next)05-01
Inst Owners64.4%
Inst Owner Change-31.82%
Ins Owners25.67%
Ins Owner Change0%
Market Cap475.49M
Revenue(TTM)76.86M
Net Income(TTM)-39.84M
Analysts76.36
Price Target10.2 (2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-13.12%
Min EPS beat(2)-18.32%
Max EPS beat(2)-7.91%
EPS beat(4)0
Avg EPS beat(4)-11.05%
Min EPS beat(4)-18.32%
Max EPS beat(4)-4.68%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.43%
Min Revenue beat(2)5.11%
Max Revenue beat(2)5.74%
Revenue beat(4)4
Avg Revenue beat(4)4.43%
Min Revenue beat(4)3.3%
Max Revenue beat(4)5.74%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-13.04%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.19
P/FCF N/A
P/OCF N/A
P/B 14.59
P/tB 19.66
EV/EBITDA N/A
EPS(TTM)-0.98
EYN/A
EPS(NY)-0.85
Fwd EYN/A
FCF(TTM)-0.72
FCFYN/A
OCF(TTM)-0.66
OCFYN/A
SpS1.62
BVpS0.69
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 55.2%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.92%
GM growth 5Y-2.23%
F-Score3
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 1.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 92.55%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.35
Quick Ratio 1.89
Altman-Z -0.16
F-Score3
WACC10.2%
ROIC/WACCN/A
Cap/Depr(3y)51.5%
Cap/Depr(5y)41.93%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%15.21%
EPS Next Y13.1%
EPS Next 2Y11.79%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.01%
Revenue growth 3Y14.87%
Revenue growth 5Y3.63%
Sales Q2Q%31.8%
Revenue Next Year18.29%
Revenue Next 2Y20.22%
Revenue Next 3Y33.84%
Revenue Next 5YN/A
EBIT growth 1Y-44.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year37.83%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-113.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-116.29%
OCF growth 3YN/A
OCF growth 5YN/A

APOLLO ENDOSURGERY INC / APEN FAQ

Can you provide the ChartMill fundamental rating for APOLLO ENDOSURGERY INC?

ChartMill assigns a fundamental rating of 2 / 10 to APEN.


What is the valuation status of APOLLO ENDOSURGERY INC (APEN) stock?

ChartMill assigns a valuation rating of 0 / 10 to APOLLO ENDOSURGERY INC (APEN). This can be considered as Overvalued.


How profitable is APOLLO ENDOSURGERY INC (APEN) stock?

APOLLO ENDOSURGERY INC (APEN) has a profitability rating of 1 / 10.


How financially healthy is APOLLO ENDOSURGERY INC?

The financial health rating of APOLLO ENDOSURGERY INC (APEN) is 2 / 10.


What is the earnings growth outlook for APOLLO ENDOSURGERY INC?

The Earnings per Share (EPS) of APOLLO ENDOSURGERY INC (APEN) is expected to grow by 13.1% in the next year.